Fig. 1

Comparisons of the PHI-r, SWLS, and PNES scores between patients with cancer at different phases of disease. The PHI-r (a), SWLS (b), PNES-positive (c), and PNES-negative (d) median scores were compared among three groups of patients: survivors (those with no evidence of disease and no antineoplastic treatment); adjuvant therapy (those with no evidence of disease but who were receiving antineoplastic treatment); and palliative care only (those with evidence of disease and not receiving antineoplastic treatment)